Recombinant human fibrinogen April 12, 2017 Recombinant human fibrinogen Trade Name Orphan Indication Bleeding in patients deficient in fibrinogen USA Market Approval USA USA Designation Date 2007-10-04 00:00:00 Sponsor Pharming Technologies B.V.;Archimedesweg 4;
